Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 21.8% in December

Silo Pharma, Inc. (NASDAQ:SILO) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 212,900 shares, a drop of 21.8% from the December 15th total of 272,100 shares. Based on an average trading volume of 2,920,000 shares, the short-interest ratio is currently 0.1 days. Approximately 5.0% of the company’s stock are short sold.

Silo Pharma Stock Down 2.8 %

Shares of NASDAQ SILO traded down $0.05 during midday trading on Wednesday, reaching $1.75. 575,190 shares of the company’s stock were exchanged, compared to its average volume of 19,772,057. Silo Pharma has a 52-week low of $0.77 and a 52-week high of $4.50. The business’s fifty day moving average price is $1.06 and its two-hundred day moving average price is $1.23.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.